In this report, according to this study, over the next five years the NK Cell Therapy Industrymarket will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026, from US$ xx million in 2020. In particular, this report presents the global market share (sales and revenue) of key companies in NK Cell Therapy Industrybusiness.
NK Cell Therapy Industry market development trend, sales volume and sales value (million USD) forecast in regional market, the main regions are China, USA, Europe, India, Japan, Korea, South America, Southeast Asia.
Sales forecast by type/application from 2021-2026
Industry chain, downstream and upstream information is also included.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of NK Cell Therapy Industry for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global NK Cell Therapy Industry market competition by top manufacturers/players, with NK Cell Therapy Industry sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Fate Therapeutics
Glycostem Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
NantWorks
Nkarta Therapeutics
Fortress Biotech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
NK Cell Therapies
NK Cell Directed Antibodies
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of NK Cell Therapy Industry for each application, including
Cancer
Gastrointestinal Diseases
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 NK Cell Therapy Industry Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 NK Cell Therapies
2.1.2 NK Cell Directed Antibodies
2.2 Overall Market Performance(Value)
2.2.1 NK Cell Therapies
2.2.2 NK Cell Directed Antibodies
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Cancer
3.1.2 Gastrointestinal Diseases
3.1.3 Others
4 Manufacturers Profiles/Analysis
4.1 Nektar Therapeutics
4.1.1 Nektar Therapeutics Profiles
4.1.2 Nektar Therapeutics Product Information
4.1.3 Nektar Therapeutics NK Cell Therapy Industry Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Nektar Therapeutics SWOT Analysis
4.2 Innate Pharma SA
4.2.1 Innate Pharma SA Profiles
4.2.2 Innate Pharma SA Product Information
4.2.3 Innate Pharma SA NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Innate Pharma SA SWOT Analysis
4.3 Affimed
4.3.1 Affimed Profiles
4.3.2 Affimed Product Information
4.3.3 Affimed NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Affimed SWOT Analysis
4.4 Chipscreen Biosciences
4.4.1 Chipscreen Biosciences Profiles
4.4.2 Chipscreen Biosciences Product Information
4.4.3 Chipscreen Biosciences NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Chipscreen Biosciences SWOT Analysis
4.5 Fate Therapeutics
4.5.1 Fate Therapeutics Profiles
4.5.2 Fate Therapeutics Product Information
4.5.3 Fate Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Fate Therapeutics SWOT Analysis
4.6 Glycostem Therapeutics
4.6.1 Glycostem Therapeutics Profiles
4.6.2 Glycostem Therapeutics Product Information
4.6.3 Glycostem Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Glycostem Therapeutics SWOT Analysis
4.7 Dragonfly Therapeutics
4.7.1 Dragonfly Therapeutics Profiles
4.7.2 Dragonfly Therapeutics Product Information
4.7.3 Dragonfly Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Dragonfly Therapeutics SWOT Analysis
4.8 Kiadis Pharma
4.8.1 Kiadis Pharma Profiles
4.8.2 Kiadis Pharma Product Information
4.8.3 Kiadis Pharma NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Kiadis Pharma SWOT Analysis
4.9 NantWorks
4.9.1 NantWorks Profiles
4.9.2 NantWorks Product Information
4.9.3 NantWorks NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.9.4 NantWorks SWOT Analysis
4.10 Nkarta Therapeutics
4.10.1 Nkarta Therapeutics Profiles
4.10.2 Nkarta Therapeutics Product Information
4.10.3 Nkarta Therapeutics NK Cell Therapy IndustrySales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Nkarta Therapeutics SWOT Analysis
4.11 Fortress Biotech
5 Market Performance for Manufacturers
5.1 Global NK Cell Therapy Industry Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global NK Cell Therapy Industry Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America NK Cell Therapy Industry Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America NK Cell Therapy Industry Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America NK Cell Therapy Industry Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America NK Cell Therapy Industry Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global NK Cell Therapy Industry Market Assessment by Regions (2014-2020)
7.1 Global NK Cell Therapy Industry Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global NK Cell Therapy Industry Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global NK Cell Therapy Industry Price (USD/Unit) by Regions 2014-2020
7.4 Global NK Cell Therapy Industry Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia NK Cell Therapy Industry Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Cancer Industry
11.2 Gastrointestinal Diseases Industry
11.3 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global NK Cell Therapy Industry Sales (K Units) and Growth Rate 2021-2026
12.1.3 China NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America NK Cell Therapy Industry Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 NK Cell Therapies
12.2.3 NK Cell Directed Antibodies
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Cancer
12.3.3 Gastrointestinal Diseases
12.3.4 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global NK Cell Therapy Industry Price (USD/Unit) Trend 2021-2026
12.4.2 Global NK Cell Therapy Industry Gross Profit Trend 2021-2026
13 Conclusion
Price : US$ 2450 |
Date : Apr 2024 |
Category : Electronics |
Pages : 269 |